Ozempic vs Wegovy cost: what the price difference really means in the UK

You've seen both names, the prices look similar, and you're wondering if it matters which one you get

It does matter, significantly. Ozempic and Wegovy are both semaglutide injections made by Novo Nordisk, but they were developed, trialled, and licensed for different purposes. Ozempic comes in doses up to 1mg weekly and is authorised in the UK for type 2 diabetes. Wegovy runs from 0.25mg up to a 2.4mg maintenance dose, with a higher 7.2mg strength now also approved by the MHRA, and it is specifically licensed for weight management in adults with a BMI of 30 or above, or 27 and above alongside a weight-related health condition. The semaglutide content differs between the two products at their respective maintenance doses, which is part of why the clinical pathways and the evidence base are not the same.

A prescriber working within UK law cannot issue Ozempic for weight loss, doing so would be an off-label use that falls outside the product's authorisation. So the Ozempic vs Wegovy cost question, when it comes to weight management, resolves itself: Wegovy is the product with the right licence, and that is what a responsible UK prescriber will use. The private cost of Wegovy in the UK reflects the dose, the clinical review, and what is bundled into the provider's pricing.

What UK private pricing for Wegovy actually covers, and what some headline figures quietly leave out

Private Wegovy pricing in the UK is quoted per pen or per month, and it varies by dose and by provider. After Eli Lilly's list-price increase in September 2025 moved market expectations upward, reported private prices for weight-loss injectables have ranged broadly, roughly £149 to £375 a month depending on the medicine, dose, and clinic. Those figures are widely cited and hedged here accordingly, because individual providers set their own prices.

What headline prices sometimes omit is worth pausing on. Consultation fees, prescription charges, and delivery costs are often listed separately, meaning the advertised number is not always the number you pay. Aftercare, dose-review support, and access to a prescriber when you have questions can carry additional charges at some services. Semaglutide injection pricing across private UK providers varies enough that comparing a single headline figure between services tells you less than you might expect.

At nume, the price is one number. It covers the consultation, the prescription, the medicine, delivery, and seven-day aftercare. We are not the cheapest option on the market, that is a deliberate choice, not an oversight. What it means in practice is that nothing is hidden and nothing is added later. Our pharmacy is GPhC-registered (registration 9012878, verifiable at the GPhC register) and every prescription comes from a clinician, not a decision tree.

Why 'cheapest' is the wrong question for a prescription semaglutide product

The MHRA has issued clear public warnings about counterfeit weight-loss pens circulating online, including fake products sold through social media and unverified websites. Some were found to contain insulin rather than the medicine they claimed to be. Sellers offering semaglutide or tirzepatide without a clinical assessment are a safety risk, not a bargain. The MHRA's Yellow Card scheme accepts reports of both suspected side effects and suspected counterfeit or illegal medicines, a useful resource if you encounter suspicious sellers.

For a prescription medicine, the right question is not which listing costs least. It is whether the supply chain is legitimate, whether a real prescriber has reviewed your health picture, and whether someone is available if something changes. Wegovy's trial evidence on weight loss comes from supervised clinical settings with proper titration and ongoing support, the context matters as much as the medicine. A small saving at the point of purchase does not offset a gap in clinical oversight.

If you're weighing up the cost difference between Ozempic and Wegovy for weight management purposes, the starting point is the licence: Wegovy is the appropriate product, and private treatment through a regulated, verifiable pharmacy is the appropriate route. If you want a closer look at whether Ozempic works out cheaper than Wegovy once dose and licensing are taken into account, that comparison is worth reading before you decide. It is also worth keeping an eye on any price cuts affecting Ozempic and Wegovy, since manufacturer and provider pricing in this market has shifted more than once in a short period. Our weight-loss treatment overview covers what is available, who it suits, and how the process works from first consultation to delivery.